Beckman Coulter has received an Emergency Use Authorization from the FDA for its Access SARS-CoV-2 IgG antibody assay.

The company said it will supply more than 30 million of the tests per month. Tests have already been shipped more than 400 hospitals, clinics and diagnostic labs in the U.S.

The serology test received CE mark certification earlier this month.